U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07400003) titled 'Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine' on Jan. 26.
Brief Summary: This clinical trial included two parts, Part A and Part B. The goal of Part A is to evaluate the safety and preliminary immunogenicity of the lyophilized herpes zoster virus mRNA vaccine (HZ mRNA vaccine) in healthy populations aged 40 years and older. The goal of Part B is to select the optimal dosage and schedule in healthy populations aged 50 years and older to support next further study.
Study Start Date: Jan. 06
Study Type: INTERVENTIONAL
Condition:
Herpes Zoster
mRNA Vaccine
Intervention:
BIOLOGIC...